NCT03916406View on ClinicalTrials.gov

THE EFFECT OF MULTIPLE DOSES OF PF-06835919 ON THE PHARMACOKINETICS OF A SINGLE ORAL MIDAZOLAM DOSE IN HEALTHY PARTICIPANTS

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 18, 2019

Primary Completion Date

June 25, 2019

Study Completion Date

June 25, 2019

Conditions
Healthy Volunteer
Interventions
DRUG

PF 06835919

300 mg

DRUG

Midazolam

7.5 mg

Trial Locations (1)

B-1070

Brussels Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03916406 - THE EFFECT OF MULTIPLE DOSES OF PF-06835919 ON THE PHARMACOKINETICS OF A SINGLE ORAL MIDAZOLAM DOSE IN HEALTHY PARTICIPANTS | Biotech Hunter | Biotech Hunter